ADAS was first reported by Jefferson et al. in 1997 (7), proposing that mutations in the COL4A3 and COL4A4 genes can lead to a spectrum of glomerular basement membrane diseases, including atypical Alport syndrome (ADAS) and familial benign hematuria. The gene discussed is COL4A3; the disease is Basement membrane disease.